Influenza Vaccination Implementation in Sri Lanka: A Cost-Effectiveness Analysis.

Neighbors, Coralei E; Myers, Evan R; Weerasinghe, Nayani P; Wijayaratne, Gaya B; Bodinayake, Champica K; Nagahawatte, Ajith; Tillekeratne, L Gayani; Woods, Christopher W

Neighbors, Coralei E; Myers, Evan R; Weerasinghe, Nayani P; Wijayaratne, Gaya B; Bodinayake, Champica K; Nagahawatte, Ajith; Tillekeratne, L Gayani; Woods, Christopher W.

Afiliação

Neighbors CE; Hubert-Yeargan Center for Global Health, Duke University, Durham, NC 27710, USA.
Myers ER; Division of Women's Community and Population Health, Department of Obstetrics & Gynecology, Duke University School of Medicine, Durham, NC 27710, USA.
Weerasinghe NP; Department of Microbiology, Faculty of Medicine, University of Ruhuna, Galle 80000, Sri Lanka.
Wijayaratne GB; Department of Microbiology, Faculty of Medicine, University of Ruhuna, Galle 80000, Sri Lanka.
Bodinayake CK; Department of Microbiology, Faculty of Medicine, University of Ruhuna, Galle 80000, Sri Lanka.
Nagahawatte A; Department of Medicine, Faculty of Medicine, University of Ruhuna, Galle 80000, Sri Lanka.
Tillekeratne LG; Duke Global Health Institute, Duke University, Durham, NC 27710, USA.
Woods CW; Department of Microbiology, Faculty of Medicine, University of Ruhuna, Galle 80000, Sri Lanka.

Vaccines (Basel) ; 11(5)2023 May 03.

Article em En | MEDLINE | ID: mdl-37243036

Palavras-chave

Markov model; Sri Lanka; cost-effectiveness; economic evaluation; influenza; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google